title: The effect of withdrawal of food iron fortification in Sweden as studied with phlebotomy in subjects with genetic hemochromatosis.
abstract: OBJECTIVE
  The iron fortification of food in Sweden, the highest in the world, was withdrawn 1st January 1995, because the effect upon target groups was considered to be uncertain. We wanted to study the effect of such a dietary experiment.
  
  
  METHODS
  Comparative cross over study.
  
  
  METHODS
  Out patient service and Blood Bank.
  
  
  METHODS
  Sixteen men aged 24-73 y on maintenance phlebotomy after treatment for iron overload. One was excluded because of inflammatory disease.
  
  
  METHODS
  Quantitative phlebotomy with serial measurements of Hb conc., % transferrin saturation and serum ferritin concentration.
  
  
  METHODS
  Iron absorption was measured by phlebotomy during two periods, with and without iron fortification. 1 g Hb = 3.4 mg Fe.
  
  
  RESULTS
  Iron absorption was significantly reduced (P < 0.001) when iron fortification was withdrawn from a mean of 4.27 +/- 1.2 to 3.63 +/- 1.1 mg/d. The difference of 0.65 mg/d (95% c.i. 0.32-0.97) corresponds to the fraction of iron derived from fortification. Intervals between donations had to be extended from 59 +/- 15 to 69 +/- 17 d (P < 0.01) to avoid induction of iron deficiency anemia. The iron content of the fortified diet averaged 15.4 mg/d, of which the fortified fraction constituted 4.1 mg/d (27%). The relative bioavailability of carbonyl iron used as fortificant was 38%.
  
  
  CONCLUSIONS
  The relative bioavailability of carbonyl iron used as fortificant was higher than previously reported. Target groups such as menstruating females will probably be affected by a higher prevalence of iron deficiency when food is no longer fortified. People with genetic hemochromatosis will accelerate into clinical disease at a slower rate.
authors.affiliation: Department of Medicine, Mölndal Hospital, Sweden.
authors.forename: K S
authors.initials: KS
authors.lastname: Olsson
authors.forename: M
authors.initials: M
authors.lastname: Väisänen
authors.forename: J
authors.initials: J
authors.lastname: Konar
authors.forename: A
authors.initials: A
authors.lastname: Bruce
mesh_terms: D000328:Adult; D000368:Aged; D001682:Biological Availability; D018592:Cross-Over Studies; D005293:Ferritins / Q000378:metabolism; D005527:Food, Fortified; D006432:Hemochromatosis / Q000097:blood / Q000178:diet therapy / Q000235:genetics*; D006801:Humans; D007408:Intestinal Absorption; D019266:Iron, Dietary / Q000008:administration & dosage* / Q000493:pharmacokinetics; D008297:Male; D008875:Middle Aged; D018962:Phlebotomy; D013548:Sweden
chemical_list: D019266:Iron, Dietary; D005293:Ferritins